Literature DB >> 24721576

Cellular DDX21 RNA helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein.

Guifang Chen1, Chien-Hung Liu1, Ligang Zhou1, Robert M Krug2.   

Abstract

Influenza A virus RNA synthesis is catalyzed by the viral polymerase comprised of the PA, pan class="Gene">PB1, and PB2 proteins. We show that the host DDX21 RNA helicase restricts influenza A virus by binding PB1 and inhibiting polymerase assembly, resulting in reduced viral RNA and protein synthesis. Later during infection, the viral NS1 protein overcomes this restriction by binding to DDX21 and displacing PB1. DDX21 binds to a region of the NS1 N-terminal domain that also participates in other critical functions. A virus mutant whose NS1 protein is unable to bind DDX21 exhibits reduced viral protein synthesis at both late and early times of infection, a phenotype converted to wild-type upon DDX21 knockdown. As sequential interaction of PB1 and NS1 with DDX21 leads to temporal regulation of viral gene expression, influenza A virus likely uses the DDX21-NS1 interaction not only to overcome restriction, but also to regulate the viral life cycle.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24721576      PMCID: PMC4039189          DOI: 10.1016/j.chom.2014.03.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  34 in total

1.  A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.

Authors:  Nicola R Donelan; Christopher F Basler; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway.

Authors:  Ji-Young Min; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

3.  Early polypeptide synthesis in influenza virus-infected cells.

Authors:  J J Skehel
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

4.  Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides.

Authors:  M Ochoa; J Bárcena; S de la Luna; J A Melero; A R Douglas; A Nieto; J Ortín; J J Skehel; A Portela
Journal:  Virus Res       Date:  1995-08       Impact factor: 3.303

5.  The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.

Authors:  Karen Y Twu; Diana L Noah; Ping Rao; Rei-Lin Kuo; Robert M Krug
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Avian flu: isolation of drug-resistant H5N1 virus.

Authors:  Q Mai Le; Maki Kiso; Kazuhiko Someya; Yuko T Sakai; T Hien Nguyen; Khan H L Nguyen; N Dinh Pham; Ha H Ngyen; Shinya Yamada; Yukiko Muramoto; Taisuke Horimoto; Ayato Takada; Hideo Goto; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2005-10-20       Impact factor: 49.962

7.  Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs.

Authors:  G I Shapiro; T Gurney; R M Krug
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

8.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

9.  Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode.

Authors:  Chen-ya Chien; Yujia Xu; Rong Xiao; James M Aramini; Parag V Sahasrabudhe; Robert M Krug; Gaetano T Montelione
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

10.  Regulation of the extent of splicing of influenza virus NS1 mRNA: role of the rates of splicing and of the nucleocytoplasmic transport of NS1 mRNA.

Authors:  F V Alonso-Caplen; R M Krug
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

View more
  51 in total

1.  Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein.

Authors:  Chien-Hung Liu; Ligang Zhou; Guifang Chen; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-26       Impact factor: 11.205

2.  Dissecting the Role of DDX21 in Regulating Human Cytomegalovirus Replication.

Authors:  Hongyun Hao; Tian Han; Baoqin Xuan; Yamei Sun; Shubing Tang; Nan Yue; Zhikang Qian
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

3.  Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication.

Authors:  Rak-Kyun Seong; Seong-Wook Seo; Ji-Ae Kim; Sarah J Fletcher; Neil V Morgan; Mukesh Kumar; Young-Ki Choi; Ok Sarah Shin
Journal:  Immunobiology       Date:  2017-07-11       Impact factor: 3.144

4.  Human DDX21 binds and unwinds RNA guanine quadruplexes.

Authors:  Ewan K S McRae; Evan P Booy; Aniel Moya-Torres; Peyman Ezzati; Jörg Stetefeld; Sean A McKenna
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

5.  A Survey of DDX21 Activity During Rev/RRE Complex Formation.

Authors:  John A Hammond; Li Zhou; Rajan Lamichhane; Hui-Yi Chu; David P Millar; Larry Gerace; James R Williamson
Journal:  J Mol Biol       Date:  2017-07-10       Impact factor: 5.469

6.  Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.

Authors:  Teresa Aydillo; Juan Ayllon; Amzie Pavlisin; Carles Martinez-Romero; Shashank Tripathi; Ignacio Mena; Andrés Moreira-Soto; Amanda Vicente-Santos; Eugenia Corrales-Aguilar; Martin Schwemmle; Adolfo García-Sastre
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 7.  Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence.

Authors:  Stefan Rothenburg; Greg Brennan
Journal:  Trends Microbiol       Date:  2019-10-06       Impact factor: 17.079

Review 8.  Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis.

Authors:  Liangmei He; Yayun Chen; Yuanbing Wu; Ying Xu; Zixiang Zhang; Zhiping Liu
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

9.  The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.

Authors:  Baoming Liu; Nan L Li; Yang Shen; Xiaoyong Bao; Thomas Fabrizio; Husni Elbahesh; Richard J Webby; Kui Li
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

10.  Interactions between the influenza A virus RNA polymerase components and retinoic acid-inducible gene I.

Authors:  Weizhong Li; Hongjun Chen; Troy Sutton; Adebimpe Obadan; Daniel R Perez
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.